ACCEL Lite: Hypertrophic Cardiomyopathy: Genetics, Natural History, Evolution and Septal Reduction Therapies
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research - Un pódcast de American College of Cardiology - Martes
Categorías:
HCM is present in 1 in 500 individuals around the world. While most patients with HCM can have a normal lifestyle and longevity, there are important issues regarding family screening, sudden cardiac arrest risk, and therapies. In this interview, Steve R. Ommen MD, FACC, and Matthew Martinez MD, FACC, discuss Hypertrophic Cardiomyopathy: Genetics, Natural History, Evolution and Septal Reduction Therapies. Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL
